Table 1.
Characteristics of tissue obtained from patients undergoing surgical resection or biopsies. The material was used for reverse transcription–polymerase chain reaction, immunohistochemical staining and cell isolation (epithelial cells, macrophages, fibroblasts).
Patient | Localization | Sex | Age | Diagnosis | Medication | Isolated tissue | Grade of inflammation |
---|---|---|---|---|---|---|---|
1 | Colon | M | 72 | Carcinoma | No medication | CEC IMAC | No inflammation |
2 | Sigma | M | 59 | Carcinoma | No medication | CEC CLPF | No inflammation |
3 | Sigma | F | 55 | Carcinoma | No medication | CEC | No inflammation |
4 | Colon | M | 63 | Carcinoma | No medication | CEC | No inflammation |
5 | Colon | F | 69 | Carcinoma | No medication | CEC IMAC | No inflammation |
6 | Sigma | F | 80 | Carcinoma | No medication | CEC | No inflammation |
7 | Sigma | M | 45 | Carcinoma | No medication | CEC CLPF | No inflammation |
8 | Rectum | F | 48 | Carcinoma | No medication | CEC IMAC | No inflammation |
9 | Rectum | M | 68 | Carcinoma | No medication | CEC | No inflammation |
10 | Rectum | M | 69 | Carcinoma | No medication | CEC | No inflammation |
11 | Colon | F | 69 | Carcinoma | No medication | IMAC | No inflammation |
12 | Rectum | F | 54 | Carcinoma | No medication | CEC | No inflammation |
13 | Ileum | M | 66 | Carcinoma | No medication | CEC IMAC | No inflammation |
14 | Colon | M | 36 | CD stenosis | Azathioprin, mesalazine, prednisolone 10 mg | CEC CLPF | Mild–severe inflammation |
15 | Colon | M | 53 | CD stenosis | No medication | CLPF | Mild–severe inflammation |
16 | Colon | F | 31 | CD stenosis | Prednisolone 5 mg | CEC CLPF | Mild inflammation |
17 | Colon | F | 37 | CD stenosis | Prednisolone 20 mg | CLPF | Severe inflammation |
18 | Colon | M | 69 | CD | Unknown | CLPF | Mild–severe inflammation |
19 | Ileocoecal | M | 23 | CD | methotrexate 15 mg | CEC CLPF | Mild inflammation |
20 | Ileum | M | 39 | CD | Prednisolone 7·5 mg | CLPF | Mild inflammation |
21 | Ileocoecal | F | 53 | CD | Budesonide | CEC CLPF | Mild inflammation |
22 | Colon | M | 38 | CD | Sulfasalazine | CEC CLPF | No − mild inflammation |
23 | Colon | F | 17 | CD | Budenoside, sulfasalazine, | CLPF | Mild inflammation |
24 | Colon | F | 42 | CD | Prednisolone 60 mg | CEC CLPF | Severe inflammation |
25 | Colon | F | 40 | CD stenosis | No medication | CLPF | Mild inflammation |
26 | Ileum | M | 43 | CD stenosis | Azathioprine, budesonide, sulfasalazine | CLPF | Mild inflammation |
27 | Colon | M | 27 | CD | Budesonide | CLPF IMAC | Mild |
28 | Colon | F | 31 | CD | No medication | CEC CLPF | No inflammation |
29 | Ileum | M | 39 | CD | Sulfasalazine | CEC | Mild inflammation |
30 | Fistula | M | 69 | CD | Unknown | CLPF | Unknown |
31 | Fistula | F | 47 | CD | Azathioprine | CLPF | Unknown |
32 | Fistula | F | 40 | CD | Sulfasalazine | CLPF | Unknown |
33 | Fistula | F | 40 | CD | Azathioprine | CLPF | Unknown |
34 | Fistula | M | 53 | CD | No medication | CLPF | Unknown |
35 | Colon | F | 39 | UC | Prednisolone 7·5 mg, budesonide | CEC CLPF | Mild inflammation |
36 | Colon | M | 42 | UC | Prednisolone 10 mg, azathioprine | CEC CLPF | Severe inflammation |
37 | Colon | M | 46 | UC | Sulfasalazine | CEC CLPF | No − mild inflammation |
38 | Colon | M | 58 | UC | No medication | CEC CLPF | Mild inflammation |
39 | Sigma | M | 37 | UC | Mesalazine | CEC | Mild |
40 | Colon | F | 46 | UC | Prednisolone 60 mg, sulfasalazine | CEC CLPF | Severe inflammation |
41 | Colon | M | 48 | UC | No medication | CEC IMAC | No inflammation |
42 | Sigma | F | 65 | Diverticulitis | No medication | CEC | No inflammation |
43 | Sigma | M | 48 | Diverticulitis | No medication | CEC | Mild inflammation |
44 | Sigma | M | 39 | Diverticulitis | No medication | CEC | Mild–severe inflammation |
CD, Crohn's disease; CEC, colonic epithelial cells; CLPF, colonic lamina propria fibroblasts; IMAC, intestinal macrophages; UC, ulcerative colitis.